We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Taste-Based Influenza Test Could Replace Nasal Swabs with Chewing Gum

By LabMedica International staff writers
Posted on 07 Oct 2025

Influenza is one of the most dangerous infectious diseases worldwide, claiming around half a million lives each year. More...

What makes it particularly insidious is that flu viruses are contagious even before the first symptoms appear. Yet, diagnostic options are often expensive, complicated to use, and unavailable in many poorer regions. Now, a new, very simple self-test in the form of chewing gum or a lollipop could detect infection within minutes by producing a recognizable taste when an active virus is present.

This rapid test, developed by researchers at the University of Würzburg (Würzburg, Germany), is based on a diagnostic principle that combines a sensor molecule (thymol, a natural flavor carrier) with a virus-specific recognition component so that active influenza viruses trigger release of the flavor in saliva. The method is flexible: flavor carrier and recognition component can be swapped (sweet, bitter, or salty flavors and alternative pathogen-specific building blocks), and the group envisions delivery formats such as chewing gum or lollipops that require no laboratory, electricity, or medical personnel.

In an experimental study, clinical samples were collected and documented by hospital teams while investigations on influenza virus particles were carried out in partner labs to validate the sensor concept. The proof-of-concept work, published in ACS Central Science, shows that contact between active influenza viruses and the neuraminidase-specific sensor releases the flavoring molecule, producing a clearly recognizable taste in infected mouths but not in uninfected controls. as.

The researchers are now working on incorporating the sensors into chewing gum or lollipops and adapting the system for mass production, a process they estimate will take about four years. They believe such low-threshold diagnostics would be particularly suitable for critical locations such as schools, nurseries, and retirement homes, and could be crucial in poorer countries for outbreak control. In the longer term, they envisage voluntary reporting via a smartphone app to map spread in real time and the use of artificial intelligence (AI) to predict where epidemics or pandemics might develop.

“Instead of relying on expensive and complicated testing procedures, we use the natural human sensory system – taste – as a tool for the early detection of infections,” said Professor Lorenz Meinel, who led the study. “This strategy opens up new possibilities for the early detection and control of influenza worldwide.”

Related Links:
University of Würzburg


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Gold Member
Platelet Function Analyzer
PL-12
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New recommendations for studying stroke recovery biomarkers could pave the way for more personalized precision rehabilitation (Image Credit: Adobe Stock)

New Biomarker Recommendations Aim to Personalize Stroke Rehabilitation

Stroke affects more than 795,000 Americans each year, leaving many survivors with lasting motor, speech, and cognitive deficits. Because rehabilitation outcomes vary widely, clinicians still face challenges... Read more

Molecular Diagnostics

view channel
Image: A research team led by Prof. Hsing I-Ming (center), Professor of the Department of Chemical and Biological Engineering at HKUST, has developed TEMPO, a thermodynamically programmed one-pot CRISPR platform for rapid, point-of-care nucleic acid testing. Mr. Wu Xiaolong (third right) and Ms. Li Yanan (first left), PhD students from the Department of Chemical and Biological Engineering, are the co-first authors of this study. (Photo courtesy of HKUST)

Single-Tube CRISPR Test Detects Pathogens and Genetic Variants in 30 Minutes

Rapid, accurate detection of infectious agents and single-nucleotide variants remains difficult to deliver outside centralized laboratories. Although multi-step nucleic acid workflows are sensitive, they... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Journal Addresses Evolving Needs in Clinical and Translational Pathology

Clinical pathology underpins diagnosis and therapy selection across oncology and other major diseases, but the field is rapidly evolving as new technologies reshape how disease is studied and classified.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.